Products for Research Use Only

L-Thyroxine sodium xhydrate

CAT: 0804-HY-W010669-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W010669-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
L-Thyroxine sodium xhydrate (Levothyroxine; T4) is a synthetic hormone in the treatment of hypothyroidism. DIO enzymes convert biologically active hormone (Triiodothyronine, T3) from L-Thyroxine (T4) .
CAS Number
25416-65-3
Product Name Alternative
Sodium levothyroxine
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
Thyroid Hormone Receptor
Type
Biochemical Assay Reagents
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/L-Thyroxine_sodium_xhydrate.html
Purity
99.30
Solubility
0.01 M NaOH : 2 mg/mL (ultrasonic; warming; adjust pH to 12 with NaOH; heat to 60°C) |DMSO : 50 mg/mL (ultrasonic)
Smiles
IC1=C(O)C(I)=CC(OC2=C(I)C=C(C[C@@](N)([H])C(O[Na])=O)C=C2I)=C1.O
Molecular Formula
C15H12I4NNaO5
Molecular Weight
816.87
Precautions
H302, H315, H319, H335
References & Citations
[1]Arici M, et al. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients. Endocr J. 2018 Jan 11.|[2]Corriveau S, et al. Levothyroxine treatment generates an abnormal uterine contractility patterns in an in vitro animalmodel. J Clin Transl Endocrinol. 2015 Sep 9;2 (4) :144-149.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Biochemical Assay Reagents
Clinical Information
Phase 4
Citation 01
Ther Deliv. 2025 Oct 30:1-15.|Cell Rep Med. 2023 Jun 20;4 (6) :101061.|Dis Model Mech. 2024 Aug 14:dmm.050748.|EMBO J. 2024 Aug;43 (15) :3090-3115.|Mol Brain. 2021 Jan 27;14 (1) :25.|Nat Immunol. 2024 Apr;25 (4) :659-670.|Sci Rep. 2022 Jul 4;12 (1) :11259.|Stem Cell Rev Rep. 2021 Jun;17 (3) :999-1013.

Chemical Information

Levothyroxine sodium monohydrate

Levothyroxine sodium hydrate is an organic molecular entity.

CAS Number25416-65-3
PubChem CID23667619
IUPAC Namesodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;hydrate
Molecular FormulaC15H12I4NNaO5
Molecular Weight816.87
Topological Polar Surface Area96.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Heavy Atom Count26
Formal Charge0
Complexity426
SMILES
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)[O-])N.O.[Na+]
InChI
InChI=1S/C15H11I4NO4.Na.H2O/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;;/h1-2,4-5,12,21H,3,20H2,(H,22,23);;1H2/q;+1;/p-1/t12-;;/m0../s1
InChIKey
ANMYAHDLKVNJJO-LTCKWSDVSA-M
Chemical Structure
2D Structure
2D structure of Levothyroxine sodium monohydrate
CAS: 25416-65-3
CID: 23667619
Formula: C15H12I4NNaO5
MW: 816.87
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight816.87
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass816.6792
Monoisotopic Mass816.6792
Topological Polar Surface Area96.6 Ų
Heavy Atom Count26
Formal Charge0
Complexity426
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes